On October 14, 2025, a new chapter in wellness officially began as Cymbiotika, the pioneering health and wellness brand known for its science-driven, premium liposomal supplements, launched nationwide at Target stores and online at Target.com. Touted as the brand’s largest retail expansion to date, and its first collaboration with a national big-box retailer — the rollout marks a defining moment for both the brand and the wider wellness industry.
The launch brings four of Cymbiotika’s bestselling products into Target’s Vitamins-Minerals-Supplements (VMS) aisle, located near pharmacy sections nationwide:
- Liposomal Glutathione
- Liposomal Vitamin C
- Liposomal Magnesium Complex
- Irish Sea Moss
Innovation Rooted in Science
The brand’s name, Cymbiotika, stems from the word symbiosis — a symbol of balance and coexistence — and the company’s mission to bridge traditional health practices with modern biotechnology. The brand quickly gained cult status for its bioavailable, liquid-based formulations anchored in liposomal delivery technology, which enhances nutrient absorption.
Liposomal supplements stand out because of how they deliver nutrients into the body. Cymbiotika’s experts explain that this method uses advanced encapsulation technology to help vitamins and minerals survive digestion and reach your system more effectively. Each nutrient is wrapped within liposomes—tiny fat-based spheres similar to the membranes that surround every cell. These microscopic “bubbles” act as a shield, protecting the active ingredients from being broken down by stomach acids until they reach the intestines, where absorption takes place. The result is better nutrient delivery, improved stability, and greater bioavailability compared with traditional supplements.
Each product is formulated with clean, potent, and traceable ingredients, ensuring that every dose performs with clinical precision.
100 Million Packets Sold and Counting
This milestone builds on years of explosive growth for the San Diego-based disruptor brand. Following impressive direct-to-consumer expansion, Cymbiotika surpassed 100 million packets sold to date, becoming one of the fastest-growing supplement businesses in North America.
With this partnership, Cymbiotika positions itself as Target’s first liposomal supplement line, filling what industry observers call a gap in the mass-market wellness aisle. Analysts from MarketScreener described this integration as a strategic breakthrough in the mainstream wellness economy — a convergence point between science, design, and accessibility.
Empowering a Movement in Wellness
For Durana Elmi, the partnership carries a message that extends far beyond store shelves.
Cymbiotika has always been about creating products people can trust, backed by science, fueled by integrity, and designed for everyday life. Seeing them on Target shelves is a moment of validation for that mission, she said. This represents not just growth for Cymbiotika, but a step forward for women entrepreneurs, proving that vision and purpose can shape entire industries.
With additional rollouts planned into 2026, Cymbiotika will expand its SKU range, introducing new categories in immune support, sleep, and beauty-from-within. Phase two of the launch will double the brand’s Target presence, aligning with the company’s new tagline: A New Era of Supplements Is Here.
Cymbiotika x Target: Where Science Meets Scale
By launching an exclusive retail line with simplified packaging and accessible price points, Cymbiotika ensures that high-quality, pharmaceutical-grade formulas once reserved for premium buyers are now available to millions.
The collaboration also reflects Target’s growing focus on holistic health and sustainability. The retailer has continued to expand its Essentials & Beauty portfolio with brands prioritizing clean ingredients, traceability, and innovation, placing Cymbiotika alongside other leaders in the modern wellness movement.
